These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22596261)

  • 21. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
    Bhattacharyya S; Cowan MJ
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again.
    Toubert A; Glauzy S; Douay C; Clave E
    Tissue Antigens; 2012 Feb; 79(2):83-9. PubMed ID: 22220718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
    Giver CR; Montes RO; Mittelstaedt S; Li JM; Jaye DL; Lonial S; Boyer MW; Waller EK
    Biol Blood Marrow Transplant; 2003 Oct; 9(10):616-32. PubMed ID: 14569558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of FoxP3+CD4+25+ regulatory T cells following hemopoietic stem cell transplantation: role of bone marrow-derived facilitating cells.
    Taylor KN; Shinde-Patil VR; Cohick E; Colson YL
    J Immunol; 2007 Aug; 179(4):2153-62. PubMed ID: 17675474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
    Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution.
    Chen BJ; Cui X; Sempowski GD; Gooding ME; Liu C; Haynes BF; Chao NJ
    Blood; 2002 Jan; 99(1):364-71. PubMed ID: 11756193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads.
    Mangare C; Tischer-Zimmermann S; Riese SB; Dragon AC; Prinz I; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity.
    Müller AM; Shashidhar S; Küpper NJ; Kohrt HE; Florek M; Negrin RS; Brown JM; Shizuru JA
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5820-5. PubMed ID: 22440752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term persistence of IL-2-unresponsive allogeneic T cells in sublethally irradiated SCID mice.
    Spaner D; Sheng-Tanner X; Raju K; Rabinovich B; Messner H; Miller RG
    Int Immunol; 1999 Oct; 11(10):1601-14. PubMed ID: 10508178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
    Martin PJ
    J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation.
    Müller AM; Linderman JA; Florek M; Miklos D; Shizuru JA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14721-6. PubMed ID: 20679222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
    Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.
    Zakrzewski JL; Kochman AA; Lu SX; Terwey TH; Kim TD; Hubbard VM; Muriglan SJ; Suh D; Smith OM; Grubin J; Patel N; Chow A; Cabrera-Perez J; Radhakrishnan R; Diab A; Perales MA; Rizzuto G; Menet E; Pamer EG; Heller G; Zúñiga-Pflücker JC; Alpdogan O; van den Brink MR
    Nat Med; 2006 Sep; 12(9):1039-47. PubMed ID: 16936725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
    Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
    Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mitochondrial protein TCAIM regulates activation of T cells and thereby promotes tolerance induction of allogeneic transplants.
    Schumann J; Stanko K; Woertge S; Appelt C; Schumann M; Kühl AA; Panov I; Schliesser U; Vogel S; Ahrlich S; Vaeth M; Berberich-Siebelt F; Waisman A; Sawitzki B
    Am J Transplant; 2014 Dec; 14(12):2723-35. PubMed ID: 25363083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lowest numbers of primary CD8(+) T cells can reconstitute protective immunity upon adoptive immunotherapy.
    Stemberger C; Graef P; Odendahl M; Albrecht J; Dössinger G; Anderl F; Buchholz VR; Gasteiger G; Schiemann M; Grigoleit GU; Schuster FR; Borkhardt A; Versluys B; Tonn T; Seifried E; Einsele H; Germeroth L; Busch DH; Neuenhahn M
    Blood; 2014 Jul; 124(4):628-37. PubMed ID: 24855206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L.
    Bachmann MF; Wolint P; Schwarz K; Jäger P; Oxenius A
    J Immunol; 2005 Oct; 175(7):4686-96. PubMed ID: 16177116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.